Inhibitors of Cyclin-Dependent Kinases as Anti-Cancer Therapeutics

By  

Current Medicinal Chemistry, Vol. 7, Iss. 12, 2000-12 ,pp. : 1213-1245

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinases and stroke

By Park David S   Wang Fuhu   O’Hare Michael J  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 5, 2001-10 ,pp. : 557-567

Informa Healthcare

Access to resources Recommend Favorite

Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein

By Wesierska-Gadek Józefa   Schmid Gerald  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 23-38

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases

By  

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 1, 2000-07 ,pp. : 107-116

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Cyclin-Dependent Kinases: Potential Drugs for the Treatment of Neurodegenerative Disorders?

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 2, 2005-01 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite